吸入器配方COPD的变化以及与恶化,医疗保健利用和成本的关联
Kevin I Duan1,2, Lucas M Donovan2,3, Laura J Spece2,3
1Division of Respiratory Medicine, University of British Columbia, Vancouver, Canada.
Chronic obstructive pulmonary diseases (Miami, Fla.)
|November 6, 2023
概括
由于配方改变而非医疗转换COPD吸入器并没有影响退伍军人的恶化或医疗费用. 需要对严重疾病和其他环境进行进一步研究.
科学领域:
- 肺部医学 肺部医学
- 医疗保健服务研究 医疗服务研究
- 药物经济学 药物经济学
背景情况:
- 处方配方剂决定了药物的可用性,频繁的变化可能需要非医疗切换.
- 非医疗转换与疾病控制和坚持性降低有关,但其对COPD的影响尚未得到充分研究.
- 形式的变化可能会影响COPD等慢性疾病的患者治疗计划.
研究的目的:
- 评估表格变化对COPD恶化,医疗保健接触和成本的影响.
- 研究使用吸入器治疗的COPD退伍军人非医疗转换的后果.
- 评估从国家表单中删除formoterol与患者结局之间的关联.
主要方法:
- 对使用吸入器治疗的10,606名患有COPD的退伍军人进行了队列研究.
- 一个2点差异分析分析了6个月前和6个月后的结果,以消除formoterol的配方.
- 结果包括COPD恶化,总体医疗保健遭遇和相关成本.
主要成果:
- 3.9%的符合条件的退伍军人 (409) 由于表格变化而更换了吸入器.
- 没有观察到COPD恶化的显著变化 ( -0.04恶化;95%CI -0.12,0.03).
- 二次结果也显示,医疗保健遭遇或成本没有显著变化.
结论:
- 由于配方药中断而转换非医疗吸入器与COPD恶化,遭遇或成本的变化无关.
- 研究结果表明,对于一些COPD患者来说,以配方驱动的非医疗转换可能不会显著改变关键的临床或经济结果.
- 建议进行进一步的研究,以验证这些发现在更严重的COPD病例和各种医疗保健环境中.
相关概念视频
Inhaled Medications
287
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
287
COPD: Management Using Bronchodilators and Corticosteroids
217
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
217
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K


